Premier Biomedical, Inc. (OTCMKTS:BIEI) Short Interest Update

Premier Biomedical, Inc. (OTCMKTS:BIEI – Get Free Report) was the target of a large growth in short interest in August. As of August 14th, there was short interest totaling 560,542 shares, a growth of 49,027.3% from the July 30th total of 1,141 shares. Based on an average daily volume of 30,713,332 shares, the days-to-cover ratio is presently 0.0 days.

Premier Biomedical Stock Performance

OTCMKTS BIEI remained flat at $0.00 during trading hours on Tuesday. The company had a trading volume of 54,000 shares, compared to its average volume of 19,638,213. Premier Biomedical has a 52-week low of $0.00 and a 52-week high of $0.00.

Get Premier Biomedical alerts:

Premier Biomedical Company Profile

(Get Free Report)

Premier Biomedical, Inc, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries.

See Also

• Five stocks we like better than Premier Biomedical
• Pathward’s Credit Scare Tests Its Comeback Story
• Wiring the AI Boom: Rumble’s $13.7B Pivot
• StoneX: Too Far Too Fast?
• DICK’s Sporting Goods Faces Pain Now for a Bigger Prize

Receive News & Ratings for Premier Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premier Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.